D. Yıldız Pehlivan, H. Yıldız, and G. Kaya, “Dapagliflozin Modulates MicroRNA Expression in Type 2 Diabetes Patients with Diabetic Nephropathy: A Retrospective Study”, Eur J Ther, vol. 31, no. 1, pp. 1–10, Feb. 2025.